プロオリゴ型核酸医薬を志向した保護基の開発研究

DOI Web Site Web Site 参考文献35件

書誌事項

タイトル別名
  • Design and Synthesis of Protecting Groups for Pro-oligo Type Nucleic Acid-based Drugs
  • プロオリゴガタ カクサン イヤク オ シコウ シタ ホゴキ ノ カイハツ ケンキュウ

この論文をさがす

抄録

<p>Oligonucleotide-based therapeutics, such as antisense oligonucleotides and small interfering RNAs(siRNAs), are fast emerging as the next generation of chemotherapeutics. However, a major issue for oligonucleotide-based therapeutics involves effective intracellular delivery of the active molecules into the cells. Several methods such as lipid nanoparticle encapsulation and conjugation of functional molecules have been reported. As an alternative approach, the use of pro-oligonucleotides (pro-oligos) offers several advantages, including improved enzymatic stability, thereby avoiding the need for transfection reagents for the delivery of oligonucleotides into cells. We have developed several bio-labile protecting groups for the pro-oligos. This article describes the design and synthesis of bio-labile protecting groups and their application to pro-oligo type molecules for the development of oligonucleotide therapeutics.</p>

収録刊行物

参考文献 (35)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ